Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects
NCT04547114 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2020-09-14
Summary
Recently published studies could demonstrate that detection of specific biomarkers in breath could be applied for the diagnosis of SARS-CoV-2.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Multicapillary column coupled ion mobility spectrometry
sampling of nasal air via a foam cuffed oxygen catheter
Sponsors & Collaborators
-
Klinikum Bayreuth GmbH
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-14
- Primary Completion
- 2020-12-31
- Completion
- 2021-04-30
Countries
- Germany
Study Locations
More Related Trials
-
Oral and Olfactory Complications of Recovered COVID-19 Patients
NCT04791436 ·Status: RECRUITING
-
the Prevalence of Oral Manifestation in Patients With SARS-CoV2 Infection
NCT04893694 ·Status: COMPLETED
-
Cigarette Smoking and Oral Microbiota
NCT01862809 ·Status: COMPLETED
-
The Salivary Raman COVID-19 Fingerprint
NCT04583306 ·Status: UNKNOWN
-
Recurrent Salivary Gland Infections in Covid-19
NCT05890547 ·Status: UNKNOWN
-
Biomarkers in Saliva and Stool
NCT03297008 ·Status: TERMINATED
-
Effectiveness of Different Candies Against Bad Breath
NCT04589481 ·Status: COMPLETED ·Phase: NA
-
Oral Symptoms of COVID-19 Among Infected Medical Doctors
NCT05697081 ·Status: COMPLETED
-
Swallowing Impairment After COVID-19 Infection
NCT04537650 ·Status: COMPLETED
-
A New Portable Monitor for Measuring Odorous Compounds in Oral, Exhaled and Nasal Air
NCT01139073 ·Status: COMPLETED
-
Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions
NCT04267419 ·Status: COMPLETED
-
Detection of Saliva by Immunoaffinity and Mass Spectrometry
NCT06183385 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population
NCT04391881 ·Status: UNKNOWN
-
EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY
NCT04657445 ·Status: COMPLETED
-
Long-Term Stability of Oral Microbiome Samples
NCT03068546 ·Status: COMPLETED
-
Oral Manifestation in Patients With SARS-CoV2 Infection.
NCT04821986 ·Status: COMPLETED
-
A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers
NCT02594449 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevalence of Oral Lesions in COVID-19 Patients
NCT04917549 ·Status: COMPLETED
-
Effect of Wearing Face Masks on Salivary Parameters and Halitosis
NCT04914208 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the Effect of Two Experimental Lozenges on Oral Malodor After Single Use
NCT05950529 ·Status: COMPLETED ·Phase: NA
-
Effect of Octreotide on Saliva
NCT05340192 ·Status: COMPLETED ·Phase: PHASE1
-
Timing of Food Intake Impacts Daily Rhythms of Human Saliva Microbiota
NCT03147703 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Stability of Sulfur Volatile Compounds From Exhaled Air for Halitosis Diagnosis
NCT06483646 ·Status: RECRUITING ·Phase: NA
-
Salivary Biomarkers for Concussion
NCT06149351 ·Status: RECRUITING
-
Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis
NCT01071616 ·Status: COMPLETED ·Phase: PHASE1